Psychedelics Investing Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors
Cannabis Investing Goodness Growth Holdings Announces Launch of Boundary Waters Pre-Rolls in Minnesota
Life Science Investing Cybin to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Psychedelics Investing Awakn Life Sciences Signs Agreement with a Leading Drug Development Company to Deepen IP Moat for Its Lead Program
Pharmaceutical Investing LYNPARZA® Approved in Japan as Adjuvant Treatment for Patients With BRCA-Mutated, HER2-Negative High Recurrent Risk Breast Cancer
Pharmaceutical Investing Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus Vaccine Candidate
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
